Literature DB >> 499237

Specificity of immunoassays. II. Heterogeneity of specificity of antibodies in antisera used for steroid immunoassay and the selective blocking of less specific antibodies, including a new method for the measurement of immunoassay specificity.

J J Pratt, M G Woldring, R Boonman, J Kittikool.   

Abstract

Practical aspects of the measurement of the specificity of immunoassay are reviewed. Antibody heterogeneity in an antiserum makes a pragmatic rather than a theoretical approach necessary. A new method for the measurement of immunoassay specificity is described. This method is based on the errors caused by the cross-reacting antigens and is directly relevant to the validity of results obtained by immunoassay methods. The effect of selectively blocking the least specific antibodies in antisera raised against steroid haptens is tested. The practical consequences of these considerations are tested using steroid radioimmunoassay and enzyme-immunoassay.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 499237     DOI: 10.1007/bf00620480

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  14 in total

1.  Estimation of plasma testosterone without extraction and chromatography.

Authors:  J J Pratt; T Wiegman; R E Lappöhn-a; M G Woldring
Journal:  Clin Chim Acta       Date:  1975-03-24       Impact factor: 3.786

2.  Radioimmunoassay of plasma estradiol without extraction and chromatography.

Authors:  H Jurjens; J J Pratt; M G Woldring
Journal:  J Clin Endocrinol Metab       Date:  1975-01       Impact factor: 5.958

3.  Immunoassay of insulin with insulin antibody precipitate.

Authors:  L STIMMLER
Journal:  Lancet       Date:  1963-03-23       Impact factor: 79.321

4.  Specificity of immunoassays. I. Effect of plasma proteins on the specificity of steroid immunoassay.

Authors:  J J Pratt; W Koops; M G Woldring; T Wiegman
Journal:  Eur J Nucl Med       Date:  1976

5.  Mathematical theory of cross-reactive radioimmunoassay and ligand-binding systems of equilibrium.

Authors:  H Feldman; D Rodbard; D Levine
Journal:  Anal Biochem       Date:  1972-02       Impact factor: 3.365

6.  Antigenic complexes of steroid hormones formed by coupling to protein through position 7: preparation from 4 -3-oxosteroids and characterization of antibodies to testosterone and androstenedione.

Authors:  A Weinstein; H R Lindner; A Friedlander; S Bauminger
Journal:  Steroids       Date:  1972-12       Impact factor: 2.668

7.  A new approach for quantitative evaluation of cross-reactivity of steroids with an antiserum by radioimmunoassay: application to a highly specific antiestriol.

Authors:  S de Lauzon; N Cittanova; B Desfosses; M F Jayle
Journal:  Steroids       Date:  1973-12       Impact factor: 2.668

8.  Solid-phase radioimmunoassay of estradiol-17 beta.

Authors:  G E Abraham
Journal:  J Clin Endocrinol Metab       Date:  1969-06       Impact factor: 5.958

9.  Radioimmunoassay specificity and the "first-come, first-served effect".

Authors:  J J Pratt; M G Woldring
Journal:  Clin Chim Acta       Date:  1976-04-01       Impact factor: 3.786

10.  [Determination of the human follicle-stimulating hormone (H.F.S.H.) by the radio-immunological method. Preliminary results obtained in the normal and hypogonadal male; in the female during the menstrual cycle and after the menopause. Effect of various pituitary inhibitors].

Authors:  G Rosselin; J Dolais
Journal:  Presse Med       Date:  1967-10-07       Impact factor: 1.228

View more
  2 in total

1.  Estimation of estradiol in mouse serum samples: evaluation of commercial estradiol immunoassays.

Authors:  Daniel J Haisenleder; Aleisha H Schoenfelder; Elizabeth S Marcinko; Lisa M Geddis; John C Marshall
Journal:  Endocrinology       Date:  2011-09-20       Impact factor: 4.736

2.  Specificity of immunoassays. III. Use of two antisera of differing specificities to improve the specificity of steroid immunoassay.

Authors:  J J Pratt; M G Woldring; R Boonman; W Bosman
Journal:  Eur J Nucl Med       Date:  1979-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.